Glenmark Pharmaceuticals has started manufacturing samples at its new plant in Indore. These samples will be shipped for the approval of the US Food and Drug Authority (USFDA) before it can launch the products at the world’s largest drug market. The company has invested 80-100 crore in the plant that has initial capacity to manufacture a million tablets per year solely for exports to US and the UK. Glenmark is hoping to get USFDA approval for the plant within a year, which will be crucial for its revenue growth from 2012 as the firm estimates it will run out of capacity in its existing manufacturing units within a year or so.crackcrack
